Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures
- PMID: 32129574
- DOI: 10.1002/ccd.28824
Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures
Abstract
Objectives: To assess national trends of acute kidney injury (AKI) incidence, incremental costs, risk factors, and readmissions among patients undergoing coronary angiography (CAG) and/or percutaneous coronary intervention (PCI) during 2012-2017.
Background: AKI remains a serious complication for patients undergoing CAG/PCI. Evidence is lacking in contemporary AKI trends and its impact on hospital resource utilization.
Methods: Patients who underwent CAG/PCI procedures in 749 hospitals were identified from Premier Healthcare Database. AKI was defined by ICD-9/10 diagnosis codes (584.9/N17.9, 583.89/N14.1, 583.9/N05.9, E947.8/T50.8X5) during 7 days post index procedure. Multivariable regression models were used to adjust for confounders.
Results: Among 2,763,681 patients, AKI incidence increased from 6.0 to 8.4% or 14% per year in overall patients; from 18.0 to 28.4% in those with chronic kidney disease (CKD) and from 2.4 to 4.2% in those without CKD (all p < .001). Significant risk factors for AKI included older age, being uninsured, inpatient procedures, CKD, anemia, and diabetes (all p < .001). AKI was associated with higher 30-day in-hospital mortality (ORadjusted = 2.55; 95% CI: 2.40, 2.70) and readmission risk (ORadjusted = 1.52; 95% CI: 1.50, 1.55). The AKI-related incremental cost during index visit and 30-day readmissions were estimated to be $8,416 and $580 per inpatient procedure and $927 and $6,145 per outpatient procedure. Overall excess healthcare burden associated with AKI was $1.67 billion.
Conclusions: AKI incidence increased significantly in this large, multifacility sample of patients undergoing CAG/PCI procedures and was associated with substantial increase in hospital costs, readmissions, and mortality. Efforts to reduce AKI risk in US healthcare system are warranted.
Keywords: acute kidney injury; chronic kidney disease; economic burden; nephropathy; percutaneous coronary intervention.
© 2020 Wiley Periodicals, Inc.
Comment in
-
The cost of non-kidney conserving catheterization.Catheter Cardiovasc Interv. 2020 Nov;96(6):1198-1199. doi: 10.1002/ccd.29354. Catheter Cardiovasc Interv. 2020. PMID: 33217185 No abstract available.
References
REFERENCES
-
- Azzalini L, Candilio L, McCullough PA, Colombo A. Current risk of contrast-induced acute kidney injury after coronary angiography and intervention: a reappraisal of the literature. Can J Cardiol. 2017;33:1225-1228.
-
- Gandhi S, Mosleh W, Abdel-Qadir H, Farkouh ME. Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med. 2014;127:987-1000.
-
- Grossman PM, Ali SS, Aronow HD, et al. Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: incidence, risk factors, and outcomes as observed in the blue cross blue shield of Michigan cardiovascular consortium. J Interv Cardiol. 2017;30:274-280.
-
- Xie X, Wan X, Ji X, et al. Reassessment of acute kidney injury after cardiac surgery: a retrospective study. Intern Med (Tokyo, Japan). 2017;56:275-282.
-
- Amin AP, Salisbury AC, McCullough PA, et al. Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med. 2012;172:246-253.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
